Top stocks to buy (AI image)

Stock market recommendations: Ipca Laboratories, and Hindalco are the top stocks that Motilal Oswal Wealth Management Research Desk has picked for this week starting March 23, 2026.

Ipca LaboratoriesIpca Laboratories is witnessing improving growth visibility driven by a recovery in its domestic formulations business and a gradual pickup in exports. The company is strengthening its domestic portfolio through therapy expansion in cardiology, pain management, and entry into high-end dermatology, while reinforcing key brands like Zerodol. Export growth is supported by increasing traction in branded markets and a steady ramp-up in generics, aided by product relaunches in the United States and participation in European tenders. The integration of the Unichem business is progressing, with focus on improving cost efficiencies through API integration and rebuilding the product pipeline, although near-term performance remains impacted by pricing pressure. Overall, improving operating leverage, portfolio optimization, and better execution across segments position the company for steady earnings growth.HindalcoHindalco remains well positioned to benefit from structural demand tailwinds across aluminum and copper, driven by electrification, renewable energy, infrastructure, and electric vehicle adoption, particularly in India where growth continues to outpace global trends. The company’s strategic focus on backward integration, including captive coal mines and renewable energy, is expected to enhance cost efficiency and margin resilience.Its ongoing expansion across upstream and downstream segments, along with increasing share of value-added products, supports long-term profitability and diversification. However, near-term performance may remain impacted by temporary disruptions at Novelis, including the Oswego plant issue and elevated capital intensity. Despite this, strong balance sheet strength, improving domestic operations, and long-term growth visibility underpin a constructive outlook.(Disclaimer: Recommendations and views on the stock market, other asset classes or personal finance management tips given by experts are their own. These opinions do not represent the views of The Times of India)